AC Immune SA
ACIU
$1.55
-$0.0402-2.53%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -382.73% | 125.28% | -23.20% | -281.31% | 68.75% |
| Total Depreciation and Amortization | -1.50% | 0.92% | -4.70% | 1.45% | 0.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.02% | -113.25% | 3,974.73% | -91.57% | 215.90% |
| Change in Net Operating Assets | 215.84% | -123.10% | 359.38% | 225.45% | -3,223.17% |
| Cash from Operations | 141.32% | -120.25% | 6,795.22% | 106.41% | -21.43% |
| Capital Expenditure | 47.54% | -159.84% | 73.60% | -51.89% | 40.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -91.85% | 97.35% | -214.17% | -200.69% | 367.73% |
| Cash from Investing | -80.56% | 97.12% | -211.13% | -202.50% | 391.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.58% | 0.58% | -3.59% | -20.14% | 0.00% |
| Issuance of Common Stock | -- | -- | 6,650.00% | -100.00% | 7,071.95% |
| Repurchase of Common Stock | -2,400.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 95.41% | -- | -- |
| Cash from Financing | -12.15% | -191.55% | 91.28% | -101.70% | 9,035.43% |
| Foreign Exchange rate Adjustments | 169.88% | -10.59% | -244.14% | 213.69% | -3,071.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.85% | -267.64% | 75.50% | -146.73% | 674.86% |
